Evidence map›Paper›PMID 42496029›Full record

ArticleChembiochem : a European journal of chemical biology2026

ChemBioParis 2025: Approaching Biology Through Chemistry in the City of Light.

Marc Panosetti, Manon Sturbaut, Marie Auvray, Lisa Gourdon-Grunenwaldt, Lina El Hajji

Abstract readConference Proceedings
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marc PanosettiDepartments of Chemistry and Pharmacology, University of Oxford, Oxford, UK.ORCID https://orcid.org/0009-0007-0375-3621
Manon SturbautCentre for Targeted Protein Degradation, University of Dundee, Dundee, UK.ORCID https://orcid.org/0000-0002-4026-2211
Marie AuvrayLaboratoire de Synthèse Organique (LSO), Ecole Polytechnique, ENSTA Paris, CNRS, Institut Polytechnique de Paris, Palaiseau, France.ORCID https://orcid.org/0000-0001-6542-3627
Lisa Gourdon-GrunenwaldtDepartment of Pharmacy, Ludwig-Maximilians Universität München, Munich, Germany.ORCID https://orcid.org/0000-0003-0932-7838
Lina El HajjiSorbonne Université, École Normale Supérieure, Université PSL, CNRS, Chimie Physique et Chimie du Vivant (CPCV), Paris, France.ORCID https://orcid.org/0009-0006-0435-9901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ten years after the last edition in Europe (Berlin 2015), Paris hosted ChemBioParis 2025, which united the International Chemical Biology Society (ICBS) annual conference and the European Chemical Biology Symposium (ECBS). Nearly 500 researchers from around the globe gathered to participate in a vibrant programme featuring keynote lectures, selected communications, two poster sessions, a trainee symposium for early-career researchers, and several social events. Researchers showcased the breadth of ongoing research in chemical biology and addressed the current challenges in the field.

Indexed as

BiochemistryDrug DiscoveryHumansSocieties, Scientificacademia/industry conferencechemical biologychemical probesdrug Discovery

Identifiers

PMID42496029
PMCPMC13398018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.